BioSpace News Archive

Business

Medable Announces Partnership with Withings Health Solutions to Integrate Connected Health Devices in Decentralized Clinical Trials

Medable Inc., the leading SaaS platform provider for patient-centered clinical trials, today announced a new partnership with Withings Health Solutions, the business-to-business division of Withings, one of the global leaders in at-home connected health.

July 21, 2022
·
3 min read
Business

Schrödinger to Announce Second Quarter 2022 Financial Results on August 4

Schrödinger (Nasdaq: SDGR), whose physics-based software platform is transforming the way therapeutics and materials are discovered, will report its second quarter 2022 financial results on Thursday, August 4, 2022, after the financial markets close.

July 21, 2022
·
1 min read
Business

Zymeworks to Host Second Quarter Results Conference Call

Zymeworks Inc. (NYSE: ZYME), a clinical-stage biopharmaceutical company developing multifunctional biotherapeutics, today announced that management will report its second quarter 2022 financial results after market close on August 4th , 2022.

July 21, 2022
·
1 min read
PharmaCyte Biotech Commences First Phase of Two-Phase Pig Study

PharmaCyte Biotech, Inc. announced today that it has commenced the pilot phase of its two-phase pig study.

July 21, 2022
·
6 min read
NLS Pharmaceutics Announces Positive Opinion from European Regulators to Grant Orphan Drug Designation for Mazindol ER in Idiopathic Hypersomnia

NLS Pharmaceutics Ltd. announces that the European Medicines Agency (EMA) Committee for Orphan Medical Products (COMP) has issued a positive opinion to grant Orphan Drug Designation for Mazindol ER.

July 21, 2022
·
8 min read
Deals

LumiraDx Announces Pricing of Public Offering of Common Shares and Concurrent Private Placement

LumiraDx Limited (Nasdaq: LMDX), a next-generation point of care (POC) diagnostics company, today announced the pricing of its underwritten public offering of 43,000,000 common shares at a price to the public of $1.75 per share.

July 21, 2022
·
6 min read
Biotech Bay

Scientific Innovation and Collaboration Highlighted at AIDS 2022 as Gilead Extends Leadership Efforts Toward Ending the Global HIV Epidemic

Gilead Sciences, Inc. (Nasdaq: GILD) today announced its upcoming contributions to the 24th International AIDS Conference (AIDS 2022).

July 21, 2022
·
15 min read
Biotech Beach

Evofem Partners with a360 Media to Support Phexxi® Prescription Growth

Evofem Biosciences, Inc., announced an agreement between Evofem and a360 Media under which Phexxi® branded content will appear in some of the most widely read entertainment and lifestyle magazines and websites in the U.S.

July 21, 2022
·
3 min read
Biotech Beach

AXIM Biotechnologies Celebrates Feature on the Vision is More Than 20/20™ Podcast

AXIM Biotechnologies, Inc. announced today that its CEO John Huemoeller has been featured on the Vision is More Than 20/20™ podcast.

July 21, 2022
·
3 min read
Business

Prime Therapeutics recognized as a Disability Equality Index® Best Place to Work for Disability Inclusion

Leading pharmacy benefit manager (PBM) Prime Therapeutics LLC (Prime) is proud to announce its score of 90 on the Disability Equality Index ® (DEI), the world’s most comprehensive benchmarking tool measuring workplace inclusion against competitors.

July 21, 2022
·
4 min read